JP6830642B2 - Drug supply device - Google Patents

Description

The present invention relates to a drug supply device.

A tablet wrapping machine is described in the microfilm (Patent Document 1) of Japanese Patent Application No. 60-37614 (Patent Document No. 61-153701). The purpose of this document is to prevent the tablet from being damaged due to collision with the hard wall of the tablet passage when the drug is dropped through the tablet passage, and to prevent the tablet from falling while bouncing, which prolongs the falling time. A configuration in which a soft sheet is suspended in the tablet passage is described.

In the apparatus described in Patent Document 1, when the tablet delivered from the tablet storage container collides with the soft sheet, the horizontal force at the time of delivery is absorbed by the soft sheet, and the tablet falls along the soft sheet. .. As a result, the time required for the drug to reach the packaging mechanism can be shortened.

Microfilm of Jitsusho 60-37614 (Jitsukai Sho 61-153701)

When the tablet collides with the soft sheet, the tablet powder may adhere to the soft sheet. If you continue to use the tablet powder with the tablet powder attached to the soft sheet, the tablet powder attached to the soft sheet may fall at an undesired timing or adhere to other tablets. There is. If such a thing occurs, foreign matter will be mixed. Therefore, it is necessary to clean the soft sheet to avoid such a situation.

However, it is difficult to clean the soft sheet because the soft sheet is easily deformed when the soft sheet is only suspended.

Therefore, an object of the present invention is to provide a drug supply device that can prevent the drug from splashing and is easy to clean.

In order to achieve the above object, the drug supply device based on the present invention includes at least one drug supply section for supplying the drug and a passage section through which the drug supplied from the drug supply section passes. A plate-shaped collided member which is a member with which the drug collides and is elastically deformable, and a cushioning member which supports the collided member from a surface opposite to the surface on which the drug collides. Is made of a material having lower resilience and lower hardness than the above-mentioned collided member.

According to the present invention, since the plate-shaped collided member is supported by the cushioning member made of a material having low resilience and low hardness, it is possible to prevent the drug from splashing. Further, since the collided member 21 can be pressed from the surface on which the chemical collides, cleaning becomes easy.

It is a perspective view of the drug supply device in Embodiment 1 based on this invention. It is a partial perspective view of the state in which the door and the like of the medicine supply device in Embodiment 1 based on this invention are opened. FIG. 5 is a partial cross-sectional view of the upper housing of the drug supply device according to the first embodiment of the present invention when viewed from the side. It is a front view in the state which the front plate of the medicine supply device in Embodiment 1 based on this invention is removed. It is a top view of the first example of a receiving structure. FIG. 5 is a cross-sectional view taken along the line of VI-VI in FIG. It is a top view of the 2nd example of a receiving structure. FIG. 7 is a cross-sectional view taken along the line VIII-VIII in FIG. It is a perspective view of the 3rd example of a receiving structure. It is sectional drawing of an example of a state in which a receiving structure is attached to one slope of a hopper. It is sectional drawing of an example of a state in which a receiving structure is attached to the surface of a trunk passage.

(Embodiment 1)
(Constitution)
The drug supply device according to the first embodiment based on the present invention will be described with reference to FIGS. 1 to 9.

The drug supply device 101 in the present embodiment supplies a drug based on a prescription. The prescription is delivered by the doctor to the patient. Prescription information is described on the prescription. Prescription information includes drug information. Drug information includes drug name, dosage, dosage and administration. The drug supply device 101 supplies a solid drug as a drug. Examples of solid agents include tablets, pills, capsules and the like. The drug supply device 101 may be provided in a drug packaging device that packages a drug based on a prescription.

The appearance of the drug supply device 101 in the present embodiment is shown in FIG. The drug supply device 101 includes a housing 1. The housing 1 includes an upper housing 2 and a lower housing 3. Doors 6a and 6b are arranged so as to be openable and closable on at least a part of the front side of the upper housing 2. Most of the doors 6a and 6b are made of a transparent material. In FIG. 1, it can be seen that a plurality of drug supply units 10 are arranged behind the doors 6a and 6b. The drug supply device 101 includes a personal computer 9 as a portion that also serves as an operation unit and a display unit. Prescription information based on the prescription is input to the personal computer 9. The personal computer 9 includes a display 4 and a keyboard 5. Other devices may be used instead of the personal computer 9. The portion that serves as both the operation unit and the display unit is not limited to a personal computer, and may be, for example, a tablet terminal. The operation unit and the display unit may be completely separate devices. As shown in FIG. 1, the drug supply device 101 may further include an operation unit 7 in addition to the personal computer 9. The drug supply device 101 includes a front plate 8 at a position lower than the doors 6a and 6b.

FIG. 2 shows a place where the door 6a of the drug supply device 101 is opened and some parts behind the door 6a are pulled out. There is a housing portion 11 behind the door 6a. The accommodating unit 11 accommodates a plurality of drug supply units 10. A back cover 12 is arranged behind the accommodating portion 11. The back cover 12 is connected to the accommodating portion 11 via a hinge and an arm 13. The back cover 12 is in contact with the accommodating portion 11 when it is housed in the upper housing 2, but the back cover 12 can be displaced away from the accommodating portion 11 when it is pulled out from the upper housing 2. .. The back cover 12 has a surface 15 so as to face the accommodating portion 11. An opening 39 is arranged on the back surface of the accommodating portion 11. An opening 16 is provided at the lower end of the back cover 12.

FIG. 3 shows a cross-sectional view of the upper housing 2 of the drug supply device 101 when viewed from the side. The left side in the figure is the front side, and the right side in the figure is the back side. A plurality of drug supply units 10 are arranged in the vertical direction. A plurality of drug supply units 10 are also arranged in the front direction of the back of the paper. Each of the plurality of drug supply units 10 contains a plurality of drugs. That is, for example, when the drug is a tablet, a plurality of tablets of the drug are contained in one drug supply unit 10. When paying attention to any one of the plurality of drug supply units 10, the drug supply unit 10 basically contains only the same type of drug. When paying attention to a plurality of drug supply units 10, in principle, different drug supply units 10 contain different types of drugs. However, for drugs that are frequently used, the same type of drug may be accommodated across a plurality of drug supply units 10. Each of the plurality of drug supply units 10 can supply the drug contained therein. The back cover 12 is arranged so as to cover the back of the arrangement of the drug supply units 10, and the internal space of the back cover 12 is a trunk passage 35 extending in the vertical direction. A passage 37 is connected in the vicinity of the back end of each drug supply unit 10. The passage 37 has a slope 38. The drug discharged from the drug supply unit 10 passes through the passage 37, passes through the opening 39, enters the main passage 35, and falls due to gravity. The drug may collide with the surface 15 as it enters the main passage 35 from the passage 37.

FIG. 4 shows a place where the front plate 8 of the drug supply device 101 is removed. In FIG. 4, the hoppers 30a and 30b are visible. The hoppers 30a and 30b are structures for receiving the chemicals falling from the main passage 35 and further guiding them to the destination. The hopper has a passage with a wide top and a narrow bottom. The drug that has fallen from the hopper passage 31a or the hopper passage 31b enters the hopper 30a. On the other hand, the drug that has fallen from the hopper passage 31c or the hopper passage 31d enters the hopper 30b. The hopper 30a has a hopper outlet 32a at the lower end. The hopper 30b has a hopper outlet 32b at the lower end.

The hopper 30a has surfaces 14a and 14b. The hopper 30b has surfaces 14c, 14d, 14e. The surfaces 14a, 14b, 14c, 14d, and 14e are all surfaces provided so that the normal vector includes an upward component. Receiving structures, which will be described later, are attached to the surfaces 14a, 14b, 14c, 14d, and 14e, respectively. Here, an example in which the receiving structure is provided only on the surface provided in the direction in which the normal vector includes the upward component is shown, but the present invention is not limited to such an example. A receiving structure may also be attached to a surface provided with the normal vector oriented so as not to include an upward component.

A first example of the receiving structure is shown in FIG. The receiving structure includes a collided member 21 and a cushioning member 22. A cross-sectional view taken along the line VI-VI in FIG. 5 is shown in FIG. The collided member 21 has a shape that matches the shape of the passage of the hopper. The collided member 21 is not limited to a rectangular shape and may have an irregular shape. In FIG. 5, the cushioning member 22 is arranged on the back side of the collided member 21 along the outer circumference of the collided member 21.

The collided member 21 may also be attached to the surface 15 of the main passage 35 shown in FIG. A second example of the receiving structure is shown in FIG. A cross-sectional view taken along the line VIII-VIII in FIG. 7 is shown in FIG. Such a thing may be stuck on the surface 15.

A third example of the receiving structure is shown in FIG. It is preferable to cover one plane with one receiving structure as much as possible, but one plane may be covered by arranging a plurality of receiving structures.

In the examples shown in FIGS. 5 to 9, the external dimensions of the cushioning member 22 are slightly smaller than the external dimensions of the collision member 21, but this is only an example, and the same external dimensions are used. There may be. The end of the cushioning member 22 is not always retracted with respect to the end of the collided member 21, and may be so-called flush. On the contrary, the end of the collided member 21 may be retracted with respect to the end of the cushioning member 22.

The drug supply device 101 includes at least one drug supply unit 10 for supplying the drug, and a passage unit through which the drug supplied from the drug supply unit 10 passes. This passage portion includes a plate-shaped collided member 21 that is a member with which the drug collides and can be elastically deformed, and a cushioning member 22 that supports the collided member 21 from a surface opposite to the surface on which the drug collides. .. The cushioning member 22 is made of a material having lower resilience and lower hardness than the collided member 21. The "passage section" includes, for example, a main passage 35. The "passage section" includes, for example, hoppers 30a and 30b.

(Action / effect)
In the present embodiment, the passage portion is provided with a plate-shaped collided member 21 that can be elastically deformed, and the collided member 21 is supported by the cushioning member 22 made of a material having low resilience and low hardness. , It is possible to prevent the drug from splashing. Since the cushioning member 22 supports the collided member 21 from the surface opposite to the surface on which the drug collides, the collided member 21 can be pressed from the surface on which the drug collides, and cleaning becomes easy. According to the present embodiment, the drug supply device can be easily cleaned in this way.

As shown in the present embodiment, it is preferable that the cushioning member 22 overlaps with the collided member 21 in a region of the collided member 21 avoiding a portion where the drug collides. The “site where the drug collides” is, for example, the central portion of the collided member 21. By adopting this configuration, the drug collides with the collided member 21 not in the region where the cushioning member 22 is behind but in the region where the cushioning member 22 is not behind, so that the chemical is collided at the time of collision. The member 21 can be elastically deformed toward the back and can absorb an impact. Thereby, the splash of the drug can be effectively reduced.

As shown in this embodiment, the cushioning member 22 is preferably provided in a frame shape. By adopting this configuration, the cushioning member 22 can stably support the collided member 21 and keep the central portion in a state where it can be freely deformed. Therefore, it is easy to absorb the impact, and the splash of the drug can be effectively reduced.

The cushioning member 22 is preferably provided linearly along the outer edge of the collided member 21. By adopting this configuration, the cushioning member 22 can efficiently support the collided member 21 with a small area.

FIG. 10 shows an example of a state in which the receiving structure is attached to one slope of the hopper 30a. The space above the collided member 21 is a hopper passage 31a. When the receiving structure is attached to the slope, it is preferable to attach the receiving structure so that there is no gap at the upper end of the receiving structure, as shown in FIG. 10, in order to prevent the chemicals from being caught. In this example, the upper end of the receiving structure has a shape that matches the vertically extending wall.

FIG. 11 shows an example of a state in which the receiving structure is attached to the surface 15 of the main passage 35. In FIG. 11, the main passage 35 extends in the direction toward the back of the paper. As shown in FIG. 2, the back cover 12 may have a structure that collectively surrounds a plurality of main passages 35, but in FIG. 11, for convenience of explanation, one back cover 12 is included in one back cover 12. An example is shown in which only the main passage 35 of the above is provided. When the main passage 35 is straight, a receiving structure as shown in FIG. 7 or 9 can also be used.

The passage portion is a back surface portion arranged so as to face the collided member 21 via a gap so as to limit the amount of elastic deformation of the collided member 21 toward the side opposite to the side on which the drug collides. 23 is preferably provided. In the examples shown in FIGS. 10 and 11, this condition is satisfied. By adopting this configuration, it is possible to perform cleaning with the collided member 21 pressed against the back surface portion 23, so that cleaning becomes easy.

The at least one drug supply unit 10 includes a plurality of drug supply units 10 arranged side by side in the vertical direction, and the length of the collided member 21 in the vertical direction is such that the plurality of drug supply units 10 are arranged in the vertical direction. It is preferable that the collided member 21 is integrally formed. If the collided member 52 is integrally formed over a sufficient length in this way, the surface on which the drug collides in the passage portion can have a seamless structure, so that the drug can be guided smoothly. Can be done. Further, since the collided member 52 is integrated and has no seam, the passage portion can be easily cleaned.

The cushioning member 22 is preferably made of a foamable resin. By adopting this configuration, the receiving structure can easily absorb the impact, and the splash of the drug can be effectively reduced.

The collision-affected member 21 is preferably made of an ultra-high molecular weight polyethylene resin. By adopting this configuration, it is possible to realize a collided member having excellent wear resistance and chemical resistance. In addition, it is possible to realize a structure in which the drug does not easily bounce off.

Up to this point, a drug supply device having a structure in which a plurality of drug supply units are arranged in parallel along a constant plane has been described as an example, but the drug supply device is not limited to such a structure. For example, the present invention can be applied to a drug supply device in which a plurality of drug supply units are arranged in a cylindrical shape.

As described in the first embodiment, "at least one", the number of drug supply units may be one or more. For example, the present invention is applied to a drug supply device having one drug supply unit. It is possible.

In addition, a plurality of the above-described embodiments may be appropriately combined and adopted.
It should be noted that the above-described embodiment disclosed this time is an example in all respects and is not restrictive. The scope of the present invention is indicated by the scope of claims and includes all modifications within the meaning and scope equivalent to the scope of claims.

1 housing, 2 upper housing, 3 lower housing, 4 display, 5 keyboard, 6a, 6b door, 7 operation unit, 8 front plate, 9 personal computer, 10 drug supply unit, 11 storage unit, 12 back cover, 13 arm, 14a, 14b, 14c, 14d, 14e plane, 15 plane, 16 opening, 21 collided member, 22 cushioning member, 23 back part, 30a, 30b hopper, 31a, 31b, 31c, 31d hopper passage, 32a , 32b Hopper outlet, 35 trunk passage, 37 passage, 38 slope, 39 opening, 101 drug supply device.

Claims (7)

With at least one drug supply unit that supplies the drug,
It is provided with a passage section through which the drug supplied from the drug supply section passes.
The passage portion includes a plate-shaped collided member that is elastically deformable and is a member with which the drug collides.
It is provided with a cushioning member that supports the collided member from a surface opposite to the surface on which the drug collides.
The cushioning member is made of a material having lower resilience and lower hardness than the collided member .
The buffer member is a drug supply device that overlaps the collided member in a region of the collided member that avoids a portion where the drug collides . The drug supply device according to claim 1, wherein the cushioning member is provided in a frame shape. The drug supply device according to claim 1 or 2 , wherein the cushioning member is linearly provided along the outer edge of the collided member. The back surface portion is arranged so as to face the collided member with a gap so as to limit the amount of elastic deformation of the collided member toward the side opposite to the side on which the drug collides. The drug supply device according to any one of claims 1 to 3, further comprising a unit. The at least one drug supply unit includes a plurality of drug supply units arranged side by side in the vertical direction.
The length of the collided member in the vertical direction corresponds to the length of the vertical arrangement of the plurality of drug supply units, and the collided member is integrally formed, according to claims 1 to 4. The drug supply device according to any one of. The drug supply device according to any one of claims 1 to 5 , wherein the cushioning member is made of a foamable resin. The drug supply device according to any one of claims 1 to 6 , wherein the collided member is made of an ultra-high molecular weight polyethylene resin.

Images